Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

被引:40
|
作者
Vokurka, S. [1 ]
Steinerova, K. [1 ]
Karas, M. [1 ]
Koza, V. [1 ]
机构
[1] Univ Hosp Plzen Pilsen, Dept Haematooncol, Plzen 30460, Pilsen, Czech Republic
关键词
oral mucositis; melphalan; stem cell transplantation; toxicity; graft-versus-host disease; VERSUS-HOST-DISEASE; HIGH-DOSE MELPHALAN; MARROW-TRANSPLANTATION; CHEMOTHERAPY; FLUDARABINE; PREVENTION; RECIPIENTS; THERAPY; MYELOMA;
D O I
10.1038/bmt.2009.66
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The fludarabine ( FLU)/melphalan (MEL) conditioning regimen containing FLU and high-dose MEL was analyzed in comparison with the BU/CY2 regimen to characterize oral mucositis ( OM) and risk factors. OM incidence significantly varied between BU/CY2 and FLU/ MEL ( 100 vs 78%, P = 0.004), but the incidence of severe OM grades 3-4 WHO and kinetics of OM were fully comparable. Patients with OM persisting on day +21 had more acute GVHD (68 vs 32%, P = 0.005), which tended to occur earlier than among those without such prolonged OM. Multivariate analysis showed significant dependency of acute GVHD on severity and prolonged duration of OM and significant correlation between OM severity and its prolonged duration. Body surface area-based dosing in the FLU/ MEL regimen led to a wide range of MEL doses administered per kilogram body weight (2.5-5.2 mg/kg, median 3.5). In multivariate analysis, MEL dose per kilogram of body weight was found to be a significant predictor of OM incidence and severity. Female gender and lower body mass index were less important variables than the fact that the actual dose of MEL administered per kilogram of body weight was relatively high when the dosage was calculated on the basis of body surface area. Bone Marrow Transplantation ( 2009) 44, 601-605; doi: 10.1038/bmt.2009.66; published online 6 April 2009
引用
收藏
页码:601 / 605
页数:5
相关论文
共 50 条
  • [1] Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2
    S Vokurka
    K Steinerova
    M Karas
    V Koza
    Bone Marrow Transplantation, 2009, 44 : 601 - 605
  • [2] Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen
    Vokurka, Samuel
    Svoboda, Tomas
    Karas, Michal
    Koza, Vladimir
    Jindra, Pavel
    Kazakov, Dmitry
    Boudova, Ludmila
    MEDICAL SCIENCE MONITOR, 2011, 17 (09): : CR480 - CR484
  • [3] Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis
    Bourdelin, M.
    Daguindau, E.
    Larosa, F.
    Legrand, F.
    Nerich, V.
    Deconinck, E.
    Limat, S.
    PATHOLOGIE BIOLOGIE, 2015, 63 (02): : 106 - 110
  • [4] Mucositis after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation
    Busemann, Christoph
    Wilfert, Hanna
    Neumann, Thomas
    Kiefer, Thomas
    Doelken, Gottfried
    Krueger, William H.
    ONKOLOGIE, 2011, 34 (10): : 518 - 524
  • [5] Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation
    Shouval, Roni
    Kouniavski, Elizaveta
    Fein, Joshua
    Danylesko, Ivetta
    Shem-Tov, Noga
    Geva, Mika
    Yerushalmi, Ronit
    Shimoni, Avichai
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) : 402 - 409
  • [6] Mouthrinse in oral mucositis in the context of allogeneic stem cell transplantation: a qualitative study
    Kroner, Anja
    Aerts, Erik
    Schanz, Urs
    Spirig, Rebecca
    PFLEGE, 2016, 29 (01): : 21 - 31
  • [7] COMPARISON OF NEW FLU-BU12-TG CONDITIONING WITH THE STANDARD BU-CY MYELOABLATIVE REGIMEN IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA
    Raida, Ludek
    Tucek, Pavel
    Faber, Edgar
    Vondrakova, Jana
    Rusinakova, Zuzana
    Skoumalova, Iva
    Hubacek, Jaromir
    Jarosova, Marie
    Katrincsakova, Beata
    Pikalova, Zuzana
    Kurfurst, Pavel
    Indrak, Karel
    BIOMEDICAL PAPERS-OLOMOUC, 2011, 155 (04): : 327 - 332
  • [8] Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients
    Legert, Karin Garming
    Remberger, Mats
    Ringden, Olle
    Heimdahl, Anders
    Dahllof, Goran
    SUPPORTIVE CARE IN CANCER, 2014, 22 (08) : 2133 - 2140
  • [9] Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation
    Berglund, Sofia
    Watz, Emma
    Remberger, Mats
    Legert, Karin Garming
    Axdorph-Nygell, Ulla
    Sundin, Mikael
    Uhlin, Michael
    Mattsson, Jonas
    VOX SANGUINIS, 2019, 114 (07) : 769 - 777
  • [10] Similar effectiveness of Fomukal and Caphosol in oral mucositis treatment after allogeneic hematopoietic stem cell transplantation
    Markiewicz, Miroslaw
    Dzieriak-Mietla, Monika
    Gaj, Magdalena
    Warzybok, Katarzyna
    Burdacki, Adrian
    Mizia, Sylwia
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 541 - 547